Effect of fluoxetine on intraocular pressure in the rabbit. 2000

C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
Eye Clinic, 2nd University of Naples, Italy.

The effects of fluoxetine, which is a selective inhibitor of serotonin reuptake (SSRI) have been studied on the intraocular pressure (IOP) in the rabbit. IOP was measured using a Perkins tonometer. Intravenous administration of fluoxetine (6.0 mg kg-1) significantly increased IOP by 7.2 +/- 1.3 mmHg (P < 0.001). Fluoxetine administration also reduced the amount of urine excreted during the 24 hr, and increased the urine concentration of 5-hydroxyindole acetic acid (5-HIAA). Topical preadministration of ketanserin prevented a rise in IOP, without there being any effects on the other parameters examined. These findings indicate that intravenous administration of fluoxetine is able to raise IOP, through increased plasma levels of serotonin, which is confirmed by elevated 5-HIAA urine excretion and reduction in diuresis. Ketanserin, a specific 5-HT2A antagonist, counteracts the IOP increase brought about by fluoxetine, thus emphasizing the role of serotonin in the regulation of IOP and stressing the importance of including ophthalmological examination in the protocol of depressed patients undergoing SSRI therapy.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D007650 Ketanserin A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione,R-41,468,R-41468,R 41,468,R 41468,R41,468,R41468
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
January 1965, Arquivos brasileiros de oftalmologia,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
July 2007, European journal of pharmacology,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
January 1977, Bericht uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
March 1971, Experimental eye research,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
July 1991, Investigative ophthalmology & visual science,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
November 1999, Investigative ophthalmology & visual science,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
February 1969, American journal of optometry and archives of American Academy of Optometry,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
January 1987, Journal of ocular pharmacology,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
January 1968, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
C Costagliola, and L Mastropasqua, and D Capone, and M Verolino, and M Ciancaglini, and N Pisanti
January 1966, Acta ophthalmologica,
Copied contents to your clipboard!